Colbar develops and manufactures a range of innovative tissue engineering products based on its patented cross-linked collagen technology. Using this breakthrough technology, Colbar can develop products with longevity and degradation rates programmed to meet specific clinical needs. Colbar's products closely mimic natural human cross-linked collagen, a key biological polymer that provides structure and strength, and supports the function of most human tissues and organs. Colbar has received funding from several venture capital firms: Vitalife, Genesis Partners, Biomedical Investments, Pitango Venture Capital and Evergreen Venture Capital.
| Website | http://www.colbar.com |
| Revenue | $7.2 million |
| Employees | 21 (6 on RocketReach) |
| Founded | 1995 |
| Address | 9 Hamenofim St, Herzliya 46733, IL |
| Industry | Medical Equipment Manufacturing, Manufacturing General, Biotechnology, Manufacturing |
| Keywords | Biotechnology, Patented Technology, Tissue Engineering, Bioscaffolds, Innovative Products, Biocompatible Materials, Biomaterials, Cellular Therapies, Regenerative Medicine, 3d Bioprinting, Pharmaceutical Manufacturing, Medical Devices, Medical Research, Biomedical Engineering, Drug Delivery, Wound Healing |
| Competitors | Medtronic, Thermo Fisher Scientific, Abbott, Stryker, Boston Scientific, Baxter International Inc., Hologic, Inc., Smith+Nephew, DJO, Impulse Monitoring +42 more (view full list) |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 532 Companies, NAICS Code 32 Companies, NAICS Code 53 Companies |
Looking for a particular ColBar LifeScience Ltd. employee's phone or email?
The ColBar LifeScience Ltd. annual revenue was $7.2 million in 2026.
6 people are employed at ColBar LifeScience Ltd..
The NAICS codes for ColBar LifeScience Ltd. are [3254, 325, 32541, 532, 32, 53].
The SIC codes for ColBar LifeScience Ltd. are [384, 38].